Your browser doesn't support javascript.
loading
Effect of ezetimibe add-on therapy over 52 weeks extension analysis of prospective randomized trial (RESEARCH study) in type 2 diabetes subjects.
Sakamoto, Kentaro; Kawamura, Mitsunobu; Watanabe, Takayuki; Ashidate, Keiko; Kohro, Takahide; Tanaka, Akira; Mori, Yasumichi; Tagami, Motoki; Hirano, Tsutomu; Yamazaki, Tsutomu; Shiba, Teruo.
Afiliação
  • Sakamoto K; Department of Diabetes and Metabolism, Toho University Ohashi Medical Center, 2-17-6, Ohashi, Meguro-ku, Tokyo, 1538515, Japan.
  • Kawamura M; Division of Endocrinology and Metabolism Department of Internal Medicine, Tokyo Teishin Hospital, Tokyo, Japan.
  • Watanabe T; Department of Internal Medicine, Yokohama City Minato Red Cross Hospital, Tokyo, Kanagawa, Japan.
  • Ashidate K; Department of Internal Medicine, Kudanzaka Hospital, Tokyo, Japan.
  • Kohro T; Department of Medical Informatics / Cardiology, Jichi Medical University, Tochigi, Japan.
  • Tanaka A; Nutrition Clinic, Kagawa Nutrition University, Tokyo, Japan.
  • Mori Y; Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan.
  • Tagami M; Sanraku Hospital, Life-style related Disease Clinic, Tokyo, Japan.
  • Hirano T; Department of Medicine Division of Diabetes Metabolism and Endocrinology, Showa University School of Medicine, Tokyo, Japan.
  • Yamazaki T; Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.
  • Shiba T; Department of Diabetes and Metabolism, Toho University Ohashi Medical Center, 2-17-6, Ohashi, Meguro-ku, Tokyo, 1538515, Japan. teruo.shiba@med.toho-u.ac.jp.
Lipids Health Dis ; 16(1): 122, 2017 Jun 24.
Article em En | MEDLINE | ID: mdl-28646901

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Ezetimiba / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Lipids Health Dis Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Ezetimiba / Anticolesterolemiantes Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: Lipids Health Dis Assunto da revista: BIOQUIMICA / METABOLISMO Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão